Greenstreet Yvonne
Insider CIK 1446125 · ALNY President & COO, Director · PCRX Director · MC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-09-19 | 2026-09-22 | 107 | — | $0 | 95,802 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-09-19 | 2026-09-22 | 107 | — | $0 | 95,802 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 129 | $320.01 | $41.3K | 98,364 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 345 | $324.88 | $112.1K | 95,960 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 135 | $319.03 | $43.1K | 98,493 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 265 | $325.67 | $86.3K | 95,695 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 274 | $320.81 | $87.9K | 98,090 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 368 | $321.82 | $118.4K | 97,722 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 444 | $323.01 | $143.4K | 97,278 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 973 | $323.84 | $315.1K | 96,305 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-03-02 | 2026-03-04 | 30,425 | — | $0 | 30,425 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-03-02 | 2026-03-04 | 110,746 | — | $0 | 110,746 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 1,098 | $325.63 | $357.5K | 103,747 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 160 | $332.64 | $53.2K | 98,628 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 346 | $330.85 | $114.5K | 99,187 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 722 | $329.71 | $238.1K | 99,533 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 424 | $328.71 | $139.4K | 100,255 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 1,399 | $327.67 | $458.4K | 100,679 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 1,669 | $326.81 | $545.4K | 102,078 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 399 | $331.93 | $132.4K | 98,788 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 382 | $324.65 | $124.0K | 104,845 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 200 | $323.62 | $64.7K | 105,227 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-03-02 | 2026-03-04 | 13,844 | — | $0 | 105,427 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2026-02-27 | 2026-03-02 | 5,921 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2026-02-27 | 2026-03-02 | 5,921 | — | $0 | 91,583 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-13 | 2026-02-17 | 6,958 | $310.08 | $2.16M | 85,662 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-02-12 | 2026-02-17 | 14,209 | — | $0 | 92,620 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 1,259 | $364.83 | $459.3K | 81,659 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 263 | $356.09 | $93.7K | 87,209 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 1,395 | $365.56 | $510.0K | 80,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 316 | $366.41 | $115.8K | 79,948 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 261 | $367.40 | $95.9K | 79,687 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 584 | $368.62 | $215.3K | 79,103 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 253 | $369.48 | $93.5K | 78,850 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 118 | $370.87 | $43.8K | 78,732 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 21 | $372.46 | $7.8K | 78,711 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 88 | $374.44 | $33.0K | 78,623 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 118 | $375.65 | $44.3K | 78,505 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 94 | $377.82 | $35.5K | 78,411 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 607 | $357.17 | $216.8K | 86,602 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 778 | $358.18 | $278.7K | 85,824 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 537 | $359.14 | $192.9K | 85,287 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 980 | $360.22 | $353.0K | 84,307 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 624 | $361.45 | $225.5K | 83,683 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 464 | $362.38 | $168.1K | 83,219 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 301 | $363.55 | $109.4K | 82,918 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 247 | $353.95 | $87.4K | 87,741 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 269 | $355.16 | $95.5K | 87,472 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-01-11 | 2026-01-14 | 19,003 | — | $0 | 87,988 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-11-26 | 2025-12-01 | 847 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-11-26 | 2025-12-01 | 659 | — | $0 | 28,141 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-11-26 | 2025-12-01 | 839 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-11-26 | 2025-12-01 | 2,352 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-11-26 | 2025-12-01 | 2,352 | $85.00 | $199.9K | 68,600 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-11-26 | 2025-12-01 | 839 | $119.13 | $100.0K | 66,248 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-11-26 | 2025-12-01 | 659 | $151.59 | $99.9K | 70,106 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-11-26 | 2025-12-01 | 847 | $118.05 | $100.0K | 69,447 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2025-11-26 | 2025-12-01 | 1,121 | $445.12 | $499.0K | 68,985 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-11-13 | 2025-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-13 | 2025-11-14 | 261 | $456.03 | $119.0K | 65,409 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-13 | 2025-11-14 | 195 | $454.69 | $88.7K | 65,670 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-13 | 2025-11-14 | 881 | $453.99 | $400.0K | 65,865 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-13 | 2025-11-14 | 1,599 | $452.85 | $724.1K | 66,746 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-13 | 2025-11-14 | 1,702 | $451.94 | $769.2K | 68,345 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-13 | 2025-11-14 | 2,218 | $450.69 | $999.6K | 70,047 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-13 | 2025-11-14 | 1,477 | $450.02 | $664.7K | 72,265 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-13 | 2025-11-14 | 1,013 | $448.76 | $454.6K | 73,742 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-13 | 2025-11-14 | 654 | $447.73 | $292.8K | 74,755 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-11-13 | 2025-11-14 | 10,000 | $119.13 | $1.19M | 75,409 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-11-12 | 2025-11-14 | 15,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-11-12 | 2025-11-14 | 650 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 1,069 | $453.52 | $484.8K | 74,229 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 1,210 | $452.43 | $547.4K | 75,298 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 1,255 | $451.16 | $566.2K | 76,508 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 453 | $450.17 | $203.9K | 77,763 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 2,132 | $449.15 | $957.6K | 78,216 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 711 | $448.07 | $318.6K | 80,348 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-11-12 | 2025-11-14 | 15,000 | $119.13 | $1.79M | 81,059 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-11-12 | 2025-11-14 | 650 | $42.22 | $27.4K | 66,059 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 1,960 | $454.84 | $891.5K | 72,269 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 604 | $457.71 | $276.5K | 65,839 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 430 | $458.42 | $197.1K | 65,409 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 3,406 | $455.56 | $1.55M | 68,863 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-11-12 | 2025-11-14 | 2,420 | $456.64 | $1.11M | 66,443 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 1,010 | $451.86 | $456.4K | 69,854 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 1,642 | $450.81 | $740.2K | 70,864 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 758 | $449.79 | $340.9K | 72,506 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 548 | $448.77 | $245.9K | 73,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 171 | $447.92 | $76.6K | 73,812 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 350 | $446.53 | $156.3K | 73,983 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 9 | $457.64 | $4.1K | 65,409 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 446 | $457.43 | $204.0K | 65,418 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 221 | $455.82 | $100.7K | 65,864 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 741 | $454.84 | $337.0K | 66,085 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 999 | $453.77 | $453.3K | 66,826 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 2,029 | $452.69 | $918.5K | 67,825 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-10-01 | 2025-10-03 | 14,252 | — | $0 | 74,333 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-10-01 | 2025-10-03 | 3,860 | — | $0 | 60,081 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 195 | $450.92 | $87.9K | 62,361 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 194 | $447.98 | $86.9K | 63,006 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 450 | $449.92 | $202.5K | 62,556 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 60 | $455.82 | $27.3K | 56,221 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 514 | $451.99 | $232.3K | 61,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 1,646 | $452.96 | $745.6K | 60,201 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 2,716 | $454.04 | $1.23M | 57,485 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 1,204 | $454.84 | $547.6K | 56,281 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-08-15 | 2025-08-19 | 14,252 | — | $0 | 63,200 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-06-02 | 2025-06-03 | 12,080 | — | $0 | 839 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-06-02 | 2025-06-03 | 7,217 | — | $0 | 847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-06-02 | 2025-06-03 | 12,080 | $119.13 | $1.44M | 61,028 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-06-02 | 2025-06-03 | 7,217 | $118.05 | $852.0K | 68,245 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-06-02 | 2025-06-03 | 19,297 | $306.00 | $5.90M | 48,948 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-05-30 | 2025-06-03 | 12,081 | — | $0 | 12,919 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-05-30 | 2025-06-03 | 19,559 | — | $0 | 8,064 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-05-30 | 2025-06-03 | 12,081 | $119.13 | $1.44M | 61,029 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-05-30 | 2025-06-03 | 19,559 | $118.05 | $2.31M | 80,588 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-30 | 2025-06-03 | 25,469 | $304.00 | $7.74M | 55,119 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-05-30 | 2025-06-03 | 6,171 | $306.00 | $1.89M | 48,948 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2025-05-16 | 2025-05-19 | 8,376 | — | $0 | 48,948 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2025-05-02 | 2025-05-06 | 41,311 | — | $0 | 57,324 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-03-03 | 2025-03-05 | 36,293 | — | $0 | 36,293 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 791 | $244.41 | $193.3K | 99,480 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 1,173 | $243.36 | $285.5K | 100,271 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 1,068 | $242.37 | $258.9K | 101,444 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-03-03 | 2025-03-05 | 17,965 | — | $0 | 102,512 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 4 | $248.36 | $993 | 98,635 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 23 | $247.35 | $5.7K | 98,639 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 238 | $246.18 | $58.6K | 98,662 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 580 | $245.26 | $142.3K | 98,900 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 127 | $239.18 | $30.4K | 87,039 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 123 | $238.33 | $29.3K | 87,166 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 158 | $236.51 | $37.4K | 87,289 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 214 | $244.11 | $52.2K | 84,547 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 284 | $240.32 | $68.3K | 86,755 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 461 | $241.51 | $111.3K | 86,294 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 1,093 | $242.44 | $265.0K | 85,201 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 440 | $243.23 | $107.0K | 84,761 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-02-27 | 2025-03-03 | 5,921 | — | $0 | 5,921 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-02-27 | 2025-03-03 | 5,921 | — | $0 | 87,447 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 38 | $260.57 | $9.9K | 81,619 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 21 | $259.72 | $5.5K | 81,657 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 59 | $258.07 | $15.2K | 81,678 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 47 | $257.51 | $12.1K | 81,737 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 98 | $256.29 | $25.1K | 81,784 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 271 | $252.50 | $68.4K | 82,468 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 201 | $254.35 | $51.1K | 81,967 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 300 | $253.37 | $76.0K | 82,168 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 47 | $261.45 | $12.3K | 81,572 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 21 | $263.33 | $5.5K | 81,551 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 25 | $264.87 | $6.6K | 81,526 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 85 | $255.56 | $21.7K | 81,882 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-02-13 | 2025-02-18 | 3,859 | — | $0 | 82,739 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 300 | $252.27 | $75.7K | 78,880 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 2,933 | $251.42 | $737.4K | 79,180 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 1,131 | $250.68 | $283.5K | 82,113 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 762 | $249.60 | $190.2K | 83,244 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 93 | $247.77 | $23.0K | 84,006 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-11-25 | 2024-11-27 | 10,658 | — | $0 | 84,099 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-08-20 | 2024-08-22 | 15,000 | — | $0 | 2,352 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-20 | 2024-08-22 | 15,000 | $280.00 | $4.20M | 73,441 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-08-20 | 2024-08-22 | 15,000 | $85.00 | $1.27M | 88,441 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-08-01 | 2024-08-02 | 15,148 | — | $0 | 17,352 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-08-01 | 2024-08-02 | 15,148 | $85.00 | $1.29M | 88,589 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-01 | 2024-08-02 | 15,148 | $270.00 | $4.09M | 73,441 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-07-11 | 2024-07-12 | 7,093 | $261.00 | $1.85M | 73,441 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 308 | $221.71 | $68.3K | 88,527 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 66 | $224.17 | $14.8K | 88,461 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 93 | $225.55 | $21.0K | 88,368 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 177 | $226.82 | $40.1K | 88,191 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 666 | $228.30 | $152.0K | 87,525 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 1,374 | $229.06 | $314.7K | 86,151 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 1,572 | $229.93 | $361.4K | 84,579 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 511 | $231.59 | $118.3K | 84,068 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 1,119 | $232.54 | $260.2K | 82,949 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 595 | $233.53 | $139.0K | 82,354 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 957 | $234.66 | $224.6K | 81,397 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 863 | $235.19 | $203.0K | 80,534 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-06-24 | 2024-06-26 | 16,953 | — | $0 | 88,835 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-03-01 | 2024-03-05 | 46,394 | — | $0 | 46,394 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-03-01 | 2024-03-05 | 23,754 | — | $0 | 71,882 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 84 | $157.30 | $13.2K | 48,136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 588 | $156.38 | $92.0K | 48,220 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 993 | $155.45 | $154.4K | 48,808 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 8 | $158.09 | $1.3K | 48,128 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 1,259 | $154.54 | $194.6K | 49,801 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-02-27 | 2024-02-29 | 5,921 | — | $0 | 11,842 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-02-27 | 2024-02-29 | 5,921 | — | $0 | 51,060 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 2,576 | $147.50 | $380.0K | 49,593 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 3,614 | $148.24 | $535.7K | 45,979 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 840 | $149.03 | $125.2K | 45,139 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-02-15 | 2024-02-20 | 16,953 | — | $0 | 52,169 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 192 | $189.31 | $36.3K | 35,216 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 771 | $184.70 | $142.4K | 38,502 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 1,869 | $185.54 | $346.8K | 36,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 17 | $188.40 | $3.2K | 35,408 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 101 | $187.37 | $18.9K | 35,425 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 1,107 | $186.39 | $206.3K | 35,526 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-08-03 | 2023-08-07 | 5,082 | — | $0 | 35,414 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-08-03 | 2023-08-07 | 3,859 | — | $0 | 39,273 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 628 | $193.18 | $121.3K | 37,319 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 2,898 | $193.93 | $562.0K | 34,421 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 3,225 | $194.94 | $628.7K | 31,196 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 533 | $197.08 | $105.0K | 30,332 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 331 | $195.65 | $64.8K | 30,865 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-04-26 | 2023-04-28 | 16,952 | — | $0 | 37,947 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 36,775 | — | $0 | 36,775 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 17,763 | — | $0 | 17,763 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 194 | $209.85 | $40.7K | 21,175 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 180 | $210.25 | $37.8K | 20,995 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 195 | $209.83 | $40.9K | 21,369 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 5,433 | $189.76 | $1.03M | 21,564 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 5,083 | — | $0 | 18,985 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 4,153 | — | $0 | 23,138 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 3,859 | — | $0 | 26,997 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2022-06-08 | 2022-06-08 | 8,225 | — | $0 | 8,225 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2022-06-08 | 2022-06-08 | 1,160 | — | $0 | 13,247 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-23 | 2022-02-25 | 31,747 | — | $0 | 31,747 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-12-31 | 2022-01-04 | 55,949 | — | $0 | 55,949 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-12-22 | 2021-12-23 | 122 | $186.55 | $22.8K | 13,902 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-12-22 | 2021-12-23 | 1 | $190.96 | $191 | 14,024 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-12-22 | 2021-12-23 | 2,415 | $189.13 | $456.7K | 14,025 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-12-21 | 2021-12-23 | 5,417 | — | $0 | 16,440 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-08-06 | 2021-08-09 | 25,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-08-06 | 2021-08-09 | 28,064 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-08-06 | 2021-08-09 | 25,000 | $77.10 | $1.93M | 64,087 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-08-06 | 2021-08-09 | 28,064 | $77.10 | $2.16M | 39,087 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-08-06 | 2021-08-09 | 53,064 | $199.00 | $10.56M | 11,023 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 7,626 | — | $0 | 7,626 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2021-06-09 | 2021-06-11 | 1,066 | — | $0 | 12,087 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 85 | $134.49 | $11.4K | 11,023 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 2,266 | $131.75 | $298.5K | 11,108 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-04-19 | 2021-04-21 | 5,083 | — | $0 | 13,374 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-02-24 | 2021-02-26 | 28,800 | — | $0 | 28,800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-02-12 | 2021-02-16 | 1,841 | $156.00 | $287.2K | 8,395 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-02-12 | 2021-02-16 | 104 | $155.84 | $16.2K | 8,291 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 8,334 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-02-11 | 2021-02-16 | 5,416 | — | $0 | 10,236 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-01-12 | 2021-01-13 | 3,125 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-01-12 | 2021-01-13 | 3,125 | $161.00 | $503.1K | 4,820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-01-12 | 2021-01-13 | 3,125 | $42.22 | $131.9K | 7,945 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-07-10 | 2020-07-14 | 46,639 | — | $0 | 28,064 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-07-10 | 2020-07-14 | 46,639 | $161.00 | $7.51M | 4,820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-07-10 | 2020-07-14 | 46,639 | $77.10 | $3.60M | 51,459 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-07-09 | 2020-07-10 | 10,939 | — | $0 | 3,125 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-07-09 | 2020-07-10 | 297 | — | $0 | 74,703 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-07-09 | 2020-07-10 | 297 | $77.10 | $22.9K | 16,056 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-07-09 | 2020-07-10 | 11,236 | $161.00 | $1.81M | 4,820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-07-09 | 2020-07-10 | 10,939 | $42.22 | $461.8K | 15,759 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 8,027 | — | $0 | 8,027 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2020-06-09 | 2020-06-11 | 1,260 | — | $0 | 11,021 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-05-06 | 2020-05-07 | 50,000 | — | $0 | 75,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-05-06 | 2020-05-07 | 50,000 | $77.10 | $3.85M | 54,820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-05-06 | 2020-05-07 | 50,000 | $150.00 | $7.50M | 4,820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-05-05 | 2020-05-07 | 6,250 | — | $0 | 650 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-05-05 | 2020-05-07 | 1,561 | — | $0 | 14,064 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-05-05 | 2020-05-07 | 6,250 | $42.22 | $263.9K | 11,070 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-05-05 | 2020-05-07 | 7,811 | $140.00 | $1.09M | 4,820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-05-05 | 2020-05-07 | 1,561 | $42.22 | $65.9K | 12,631 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 98 | $107.47 | $10.5K | 4,820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2020-04-07 | 2020-04-09 | 5,417 | — | $0 | 7,333 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 2,415 | $104.75 | $253.0K | 4,918 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-02-26 | 2020-02-28 | 27,623 | — | $0 | 27,623 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-02-10 | 2020-02-11 | 5,600 | — | $0 | 6,900 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-02-10 | 2020-02-11 | 5,600 | $42.22 | $236.4K | 11,808 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-10 | 2020-02-11 | 9,892 | $130.00 | $1.29M | 1,916 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-02-07 | 2020-02-11 | 6,250 | — | $0 | 12,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-07 | 2020-02-11 | 6,250 | $123.90 | $774.4K | 6,208 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-02-07 | 2020-02-11 | 6,250 | $42.22 | $263.9K | 12,458 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-12-23 | 2019-12-26 | 8,333 | — | $0 | 16,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2019-12-12 | 2019-12-13 | 7,500 | — | $0 | 9,416 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2019-12-12 | 2019-12-13 | 3,208 | $120.61 | $386.9K | 6,208 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-11-22 | 2019-11-26 | 8,333 | — | $0 | 8,333 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-11-20 | 2019-11-22 | 6,250 | — | $0 | 18,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-11-20 | 2019-11-22 | 2,154 | — | $0 | 15,625 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-11-20 | 2019-11-22 | 6,250 | $42.22 | $263.9K | 10,320 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-11-20 | 2019-11-22 | 2,154 | $42.22 | $90.9K | 4,070 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-11-20 | 2019-11-22 | 8,404 | $105.00 | $882.4K | 1,916 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-08-06 | 2019-08-07 | 6,250 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-07-11 | 2019-08-07 | 50 | — | $0 | 407 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2019-06-05 | 2019-06-06 | 8,437 | — | $0 | 8,437 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-06-05 | 2019-06-07 | 6,250 | — | $0 | 18,750 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2019-06-05 | 2019-06-06 | 4,134 | — | $0 | 9,761 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-04-09 | 2019-06-07 | 49 | — | $0 | 357 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-02-28 | 2019-03-01 | 32,500 | — | $0 | 32,500 | SEC↗ |
| MC Moelis & Co | A Award | 2018-11-14 | 2018-11-16 | 12 | — | $0 | 1,059 | SEC↗ |
| MC Moelis & Co | A Award | 2018-11-14 | 2018-11-16 | 8 | — | $0 | 706 | SEC↗ |
| MC Moelis & Co | A Award | 2018-11-14 | 2018-11-16 | 13 | — | $0 | 1,157 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 6,250 | — | $0 | 12,500 | SEC↗ |
| MC Moelis & Co | A Award | 2018-09-12 | 2018-09-14 | 48 | — | $0 | 1,396 | SEC↗ |
| MC Moelis & Co | A Award | 2018-09-12 | 2018-09-14 | 39 | — | $0 | 1,144 | SEC↗ |
| MC Moelis & Co | A Award | 2018-09-12 | 2018-09-14 | 24 | — | $0 | 698 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-08-30 | 2018-09-04 | 2,500 | $120.00 | $300.0K | 1,916 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-13 | 2018-08-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2018-08-13 | 2018-08-14 | 3,084 | $90.95 | $280.5K | 4,416 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2018-08-13 | 2018-08-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-07-10 | 2018-08-14 | 38 | — | $0 | 308 | SEC↗ |
| MC Moelis & Co | A Award | 2018-07-02 | 2018-07-03 | 674 | — | $0 | 674 | SEC↗ |
| MC Moelis & Co | A Award | 2018-07-02 | 2018-07-03 | 1,348 | — | $0 | 1,348 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2018-06-13 | 2018-06-15 | 4,693 | — | $0 | 4,693 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2018-06-13 | 2018-06-15 | 782 | — | $0 | 5,627 | SEC↗ |